Table 3.
Inhibitor of ALKBH1.
| Interactions between the inhibitors and ALKBH1 [112] | |||
|---|---|---|---|
| Binding Site | Mechanism | Inhibitors | Residues of ALKBH1 |
| 2-OG binding site | salt bridge interaction with –COOH | LipotF, citrate,2,4-PDCA,NOG,IOX1,IOX3 | Arg338 |
| hydrogen bonding with C O/-COOH/-OH | 2,4-PDCA,NOG,rhein, fluorescein | Arg 334 | |
| hydrogen bonding with C O/-COOH/-OH | citrate,NOG,entacapone | Asn220 | |
| hydrogen bonding with –COOH | LipotF,2,4-PDCA,NOG,IOX1,IOX3 | Asn340 | |
| hydrogen bonding with –COOH | LipotF,2,4-PDCA,NOG,IOX3 | Met 376 | |
| substrate-binding site | water-mediated bond | FB23 | Arg 234 |
| Hydrogen bonding with pyridyl nitrogen/-OH/nitrogen or oxygen atom of heterocyclic ring | LipotF, CHTB | ||
| π-π interactions with -C6H5 | rhein, CHTB,LipotF | His 231 | |
| hydrogen bonding with –OH | CHTB | Val 232 | |
| π-π interactions with -C6H5 | LipotF | Tyr177 | |
| hydrogen bonding with –OH | entacapone | Tyr184 | |
| hydrogen bonding with –OH | CDPCB | Phe 27 | |
| Van der Waals contact with -Cl | CDPCB | Leu 228 | |
| hydrophobic interaction with --C6H5 | LipotF | ||